Risk factors for regional lymph node metastasis in rectal neuroendocrine tumors: a population-based study
- PMID: 39296902
- PMCID: PMC11408165
- DOI: 10.3389/fmed.2024.1383047
Risk factors for regional lymph node metastasis in rectal neuroendocrine tumors: a population-based study
Abstract
Introduction: The identification of risk factors for regional lymph node (r-LN) metastasis in rectal neuroendocrine tumors (R-NETs) remains challenging. Our objective was to investigate the risk factors associated with patients diagnosed with R-NETs exhibiting r-LN metastasis.
Methods: Patient information was obtained from the Surveillance, Epidemiology, and End Results (SEER) database, complemented by data from the West China Hospital (WCH) databases. The construction cohort comprised patients diagnosed with R-NETs from the SEER database, while cases from the WCH database were utilized as the validation cohort. A novel nomogram was developed to predict the probability of r-LN metastasis, employing a logistic regression model.
Results: Univariate analysis identified four independent risk factors associated with poor r-LN metastasis: age (HR = 1.027, p < 0.05), grade (HR = 0.010, p < 0.05), T stage (HR = 0.010, p < 0.05), and tumor size (HR = 0.005, p < 0.05). These factors were selected as predictors for nomogram construction.
Discussion: The novel nomogram serves as a reliable tool for predicting the risk of r-LN metastasis, providing clinicians with valuable assistance in identifying high-risk patients and tailoring individualized treatments.
Keywords: SEER; West China hospital databases; rectal neuroendocrine tumors; regional lymph node metastasis; tumor size.
Copyright © 2024 Li, Li, Wang, Chang, Lv, Li and Cao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?Ann Surg Oncol. 2024 Apr;31(4):2414-2424. doi: 10.1245/s10434-023-14829-x. Epub 2024 Jan 9. Ann Surg Oncol. 2024. PMID: 38194045
-
Predict Lymph Node Metastasis in Penile Cancer Using Clinicopathological Factors and Nomograms.Cancer Manag Res. 2021 Sep 24;13:7429-7437. doi: 10.2147/CMAR.S329925. eCollection 2021. Cancer Manag Res. 2021. PMID: 34594135 Free PMC article.
-
Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.Front Endocrinol (Lausanne). 2022 Jul 21;13:871830. doi: 10.3389/fendo.2022.871830. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35937823 Free PMC article.
-
Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.Front Endocrinol (Lausanne). 2024 Feb 14;15:1264952. doi: 10.3389/fendo.2024.1264952. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38449852 Free PMC article.
-
Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and Its Prognostic Impact: A Single-Center Retrospective Analysis of 195 Cases with Radical Resection.Ann Surg Oncol. 2023 Jul;30(7):3944-3953. doi: 10.1245/s10434-023-13348-z. Epub 2023 Mar 19. Ann Surg Oncol. 2023. PMID: 36935432
Cited by
-
Current status of endoscopic resection for small rectal neuroendocrine tumors.World J Gastroenterol. 2025 May 21;31(19):106814. doi: 10.3748/wjg.v31.i19.106814. World J Gastroenterol. 2025. PMID: 40497093 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources